Non-Functioning Somatostatinoma of the Duodenum in Patient with Von Recklinghausen's Disease

Von Recklinghausen's Disease 환자의 십이지장에 발생한 비기능성 Somatostatinoma 1예

  • Kim, Kang-Jae (Department of General Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jang, Kee-Taek (Department of General Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Woo-Seok (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Choi, Dong-Wook (Department of General Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 김강재 (성균관대학교 의과대학 삼성서울병원 외과학교실) ;
  • 장기택 (성균관대학교 의과대학 삼성서울병원 외과학교실) ;
  • 김우석 (성균관대학교 의과대학 삼성서울병원 병리학교실) ;
  • 최동욱 (성균관대학교 의과대학 삼성서울병원 외과학교실)
  • Published : 2009.12.31

Abstract

Somatostatinoma is a rare endocrine tumor that comprises around 1% of all gastroentero-pancreatic endocrine neoplasm. The estimated annual incidence is 1 in 40 million. This tumor may be associated with von Recklinghausen's disease. We present here a rare case of a 51-year-old female patient with a duodenal nonfunctioning somatostatinoma combined with von Recklinghausen's disease. Whipple' procedure was performed. The postoperative course was uneventful and the histopathologic findings were consistent with malignant nonfunctioning somatostatinoma with lymph node metastases. The patient is alive, healthy and without tumor recurrence 10 months after surgery.

Keywords

References

  1. Nesi G, Marcucci T, Rubio CA, Brandi ML, Tonelli F. Somatostatinoma: clinico- pathological features of three cases and literature reviewed. J Gastroenterol and Hepatol 2008; 23:521-526. https://doi.org/10.1111/j.1440-1746.2007.05053.x
  2. Larsson LI, Hirsch MA, Holst JJ, et al. Pancreatic somatostatinoma. Clinical feature and physiological implications. Lancet 1977;1:666-668.
  3. Kaneko H, Yanaihara N, Ito S, et al. Somatostatinoma of the duodenum. Cancer 1979;44:2273-2279. https://doi.org/10.1002/1097-0142(197912)44:6<2273::AID-CNCR2820440641>3.0.CO;2-U
  4. Mao C, Shah A, Hanson DJ, Howard JM. Von recklinghausen's disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas. J Surg Oncol 1995;59:67-73 https://doi.org/10.1002/jso.2930590116
  5. Capella C, Heitz P, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Archiv 1995;425:547-560.
  6. Blaser A, Vajda P, Rosset P. Duodenal somatostatinomas associated with von recklinghausen disease. Schweiz Med Wochenschr 1998;128:1984-1987.
  7. Green BT, Rockey DC. Duodenal somatostatinoma presenting with complete somatostatinoma syndrome. J Clin Gastroenterol 2001;33:415-417. https://doi.org/10.1097/00004836-200111000-00015
  8. Hamy A, Heymann MF, Bodic J, et al. Duodenal somatostatinoma. Anatomic/clinical study of 12 operated cases. Ann Chir 2001;126:221-226. https://doi.org/10.1016/S0003-3944(01)00493-X
  9. Taccagni GL, Curlucci M, Sironi M, Cantaboni A, Di Carlo V. Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study. Am J Gastroenterol 1986;81:33-37.
  10. Hamissa S, Rahmouni A, Coffin C, Wolkenstein P. CT detection of an ampullary somatostatinoma in a patient with von recklinghausen's disease. AJR Am J Roentgenol 1999; 173:503-504.
  11. Angeletti S, Corleto VD, Schillaci O, et al. Use of the somatostatin analogue octerotide to localized and manage somatostatin-producing tumor. Gut 1998;42:792-794. https://doi.org/10.1136/gut.42.6.792
  12. Krausz Y, Bar-Ziv J, de Jong RB, et al. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors. Am J Gastroenterol 1998;93:66-70. https://doi.org/10.1111/j.1572-0241.1998.066_c.x
  13. Dayal Y, Doos WG, O'Brien MJ, Nunnemacher G, DeLellis RA, Wolfe HJ. Psammomatous somatostatinomas of the duodenum. Am J Surg Pathol 1983;7:653-665. https://doi.org/10.1097/00000478-198310000-00006
  14. Harris GJ, Tio F, Cruz AB Jr. Somatostatinoma: a case report and review of the literature. J Sur Oncol 1987;36:8-16. https://doi.org/10.1002/jso.2930360104
  15. O'brien TD, Chejfec G, Prinz RA. Clinical features of duodenal somatostatinomas. Surgery 1993;114:1144-1147.
  16. Pipeleers D, Couterier E, Gepts W, Reynders J, Somers G. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia. J Clin Endocrinol Metab 1983;56:1236- 1242. https://doi.org/10.1210/jcem-56-6-1236
  17. Modlin IM, Lewis JJ, Ahlman H, Bilchik AJ, Kumar RR. Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet 1993;176:507-518.
  18. Echhauser FE, Colletti LM. Somatostatinoma. Pancreas 1998; 2:1270-1274.
  19. Tanaka S, Yamasaki S, Matsushita H, et al. Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis. Pathol Int 2000;50:146-152. https://doi.org/10.1046/j.1440-1827.2000.01016.x